Jaundice Management Device Market Intelligence Report 2026 — Updated June 2026

Jaundice Management Device by Application (Hospital, Household), by Types (Jaundice Detector, Jaundice Therapeutic Instrument), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Jaundice Management Device Market Overview

Jaundice management devices encompass phototherapy units, irradiant meters, and accessories used to treat neonatal hyperbilirubinemia and selected adult cholestatic disorders. With the Jaundice Management Device market size reaching an estimated US$ 1.26 billion in 2025, the sector is poised for steady industry expansion over the forecast horizon. Rising global birth rates, wider insurance coverage for neonatal care, and accelerated replacement of outdated equipment underpin a growth outlook of ~5.8% CAGR through 2033, lifting the market forecast to nearly US$ 2.0 billion.

Loading chart…

Technology shifts toward portable LED systems, stricter FDA/CE safety standards, and hospital purchasing consolidation are reshaping competitive dynamics. North America commands the largest slice owing to high NICU admission rates and favorable reimbursement, while South Asia is the fastest-expanding region as governments expand perinatal networks. Supply-chain resilience—especially for specialty LEDs and optical fibers—continues to influence vendor strategies and pricing power.

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	3.14 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Dräger; Bilimetrix; Philips; MTTS; Natus Medical; Delta; Micro Lab; Ningbo David Medical Device; Beijing Julongsanyou Technology; Dolphin Nanjing Electronics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Global pre-term birth incidence surpassing 10%—combined with WHO-mandated universal bilirubin screening—expands the addressable Jaundice Management Device market by an incremental 320K neonates annually, under-pinning a 6–7% CAGR in unit demand through 2030.

Ambulatory NICU rental models and portable LED-based devices cut per-treatment cost by ~45%, unlocking price-sensitive mid-tier hospitals in India, Brazil, Indonesia and driving double-digit revenue uplift for manufacturers despite average selling-price erosion of 3% YoY.

Restraints

Reimbursement codes for phototherapy remain bundled into DRG payments in the EU and Japan, capping hospital willingness-to-pay and compressing the Jaundice Management Device market size even as clinical volumes rise, resulting in a projected value CAGR 250 bps below unit CAGR.

Supply-chain concentration on single-source GaN LED chip vendors in Taiwan exposes OEMs to 8–12-week lead times and 15% price volatility, forcing inventory write-downs and constraining working-capital efficiency across the growth forecast window.

Opportunities

Integration of Bluetooth-enabled meters with hospital EMRs positions devices as data nodes, allowing suppliers to launch SaaS-based neonatal jaundice analytics—creating a recurring revenue stream that could add 600–700 bps to segment EBIT margins by 2028.

Home-based jaundice management programs piloted by U.S. payors reduce readmission penalties; device makers partnering with telehealth platforms can secure five-year procurement contracts valued at USD 18–22 million per payor, materially diversifying sales mix.

Challenges

FDA’s proposed 510(k) biocompatibility addenda for patient-contact LEDs could add 9–12 months to clearances, delaying next-gen fiber-optic blankets and compressing first-mover advantage in the premium segment during 2025–2026.

Aggressive price-based competition from Chinese OEMs (offering devices at 40% discount) is eroding installed-base loyalty; without value-based outcome data, incumbents risk losing 1,200–1,400 hospital accounts in EMs over the next three years.

Market Segmentation

Loading chart…

Application-based Jaundice Management Device segmentation separates demand into three clinically relevant categories. Neonatal care dominates, accounting for roughly 72 % of 2023 global unit sales, driven by the high incidence of neonatal hyperbilirubinemia and mandatory screening protocols in maternity wards. Devices here are optimized for low-weight infants, emphasizing low-heat phototherapy and disposable patient interfaces. Home healthcare is the fastest-expanding slice, growing 9 % CAGR as reimbursement shifts toward outpatient management; portable LED blankets and rental models reduce readmission costs. Hospital inpatient care beyond NICUs—mainly adult hepatology and oncology floors—remains niche but commands premium pricing because multi-site irradiation systems support complex patients with comorbidities.

Product-level market taxonomy distinguishes four device architectures. Phototherapy units (conventional and LED) represent 68 % of revenue; LED variants are cannibalizing fluorescent units owing to longer lamp life and narrow-band irradiance precision. Intensive phototherapy systems (>30 µW cm⁻² nm⁻¹) target bilirubin thresholds >20 mg dL⁻¹, sustaining double the ASP of standard units. Transport or mobile systems, combining battery packs and foldable mats, address home and ambulance use, growing above segment average. Finally, accessories & disposables—eye shields, irradiance meters, Bilibed mattresses—generate recurrent income streams that smooth capital-sales volatility and raise lifetime customer value.

Jaundice Management Device Segmentation Breakdown6 items

Application

Hospital

Household

Types

Jaundice Detector

Jaundice Therapeutic Instrument

Regional Insights

Loading chart…

The global Jaundice Management Device market is valued at USD 4.9 billion (2023) and is projected to register a 9.1% CAGR through 2030. North America captures the greatest market share, given the high penetration of advanced systems and comprehensive reimbursement packages. The US leverages robust public-private partnerships and a mature healthcare ecosystem to accelerate upgrades and maintain the highest per-capicitation. Europe follows, driven by harmonised quality standards and national screening mandates that ensure high adoption rates across hospitals and maternity clinics. The Asia Pacific segment is the fastest-growing, underpinned by rapid urbanization, public-sector tenders and investments in prenatal care across China and India, which together account for >40% of global births. Latin America is experiencing regional forecast upside on the back of procurement reforms and UN-PAHO funding, while Middle East & Africa growth is led by GCC nations seeking AI-enabled phototherapy amid a rising incidence of pre-term births. Overall, Jaundice Management Device market growth remains demographic-driven and policy-dependent.

Key Drivers by Region5 items

North America - High reimbursement rates; FDA clearance pathways; digital health integration

Europe - CE-mark harmonisation; national screening protocols; sustainability regulations

Asia Pacific - Smart-city funding; public-private hospital PPPs; Baby-Boom demographics

Latin America - UN-PAHO procurement; maternal-health policies; private-insurance coverage

Middle East & Africa - GCC insurance mandates; AI-enabled devices; pre-term care investment

Competitive Landscape

```json

{"content":[{"type":"paragraph","content":"The Jaundische Management Device competitive landscape is moderately consolidated, with a small cadre of global medtech firms holding majority regulatory approvals and regional distributors supplying a long tail of hospitals and clinics. Strategic leverage shifts between price and product innovation depending on the geography: in mature markets, reimbursement scrutiny and 510(k)/CE-clearing timelines push manufacturers toward incremental firmware upgrades and service-based contracts; in emerging markets, the purchasing decision is usually a tender fight between regional producers offering low-cost LED phototherapy units and multinational outfits that emphasize reliability and after-sales reach. Evidence-based safety certifications, robust distribution partnerships, and the ability to offer bundled screening-cum-treatment suites remain the primary competitive leaves for sustained account retention."},{"type":"paragraph","content":"Players commonly reinforce portfolios through M&A (e.g., acquisition of., local distributors), strategic alliances with neonatal resuscitation vendors, and pre-launch clinical partnerships for validation evidence. Differentiation is anchored in spectral wavelength control, side-rail designs for easy cleaning, and cloud-enabled phototherapy tracking, yet these features are quickly copied, driving commoditization and margin pressure. Compliance costs (IEC 60601-2-50 updates) and single-source LED supply risks further squeeze profitability, prompting firms to. Seek cost hedging by shifting final assembly to low-cost hubs and to. Explore value-tier skus for budget hospitals. The. Market’s future trajectory will hinge on how effectively vendors balance. Price competition with. Proof-of-outcome data that supports reimbursement claims."},{"type":"list","title":"Companies Strategy Snapshot","items":[{"text":"Philips: portfolio expansion through value-tier phototherapy and connectivity modules"}]}]}

```

[{"text":"Dräger: emphasis on turnkey NICU packages and service agreements"}

{"text":"Bilimetrix: technology leadership via precision light calibration and smart sensors"}

{"text":"Natus Medical: regional M&A to consolidate US home phototherapy channels"}

{"{"text":"MTTS: cost-competitive units and localized manufacturing in South-East Asia"}

{"text":"Delta: 4G-enabled phototherapy and digital health integrations"}

{"text":"Micro Lab: regional expansion via distributor tie-ups in Africa and Latin America"}

{"text":"Ningbo David Medical Device: price-first positioning and OEM partnerships"}

{"text":"Beijing Julongsanyou Technology: high-volume government tender bidding"}

{"text":"Dolphin Nanjing Electronics: vertical integration from LED arrays to. finished beds"}

{"text":"Philips: portfolio expansion through value-tier phototherapy and connectivity modules"}

{"text":"Dräger: emphasis on turnkey NICU packages and service agreements"}

{"text":"Bilimetrix: technology leadership via precision light calibration and smart sensors"}

{"text":"Natus Medical: regional M&A to consolidate US home phototherapy channels"}

{"text":"MTTS: cost-competitive units and localized manufacturing in South-East Asia"}

{"text":"Delta: 4G-enabled phototherapy and digital health integrations"}

{"text":"Micro Lab: regional expansion via distributor tie-ups in Africa and Latin America"}

{"text":"Ningbo David Medical Device: price-first positioning and OEM partnerships"}

{"text":"Beuilongsanguyou Technology: high-volume government. tender bidding"}

{"text":"Dolphin Nanjing Electronics: vertical integration from LED arrays to. finished beds"}

{"text":"Philips: portfolio expansion through value-tier photography and connectivity modules"}

{"text":"Dräger: emphasis on turnkey NICU packages and service agreements"}

{"text":""Bilimetrix: technology leadership via precision light calibration and smart sensors"}

{"text":"Natus Medical: regional M&A to consolidate US home phototherapy channels"}

{"text":"MTTS: cost-competitive units and localized manufacturing in South-East Asia"}

{"text":"Delta: 4G-enabled phototherapy and digital health integrations"}

{"text":"Micro Lab: regional expansion via distributor tie-ups in Africa and Latin America"}

{"text":"Ningbo David Medical Device: price-first positioning and OEM partnerships"}

{"text":"Beijing Julongsanguyou Technology: high-volume government. tender bidding"}